DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment.

by Rosanna Villani, Antonio Facciorusso, Francesco Bellanti, Rosanna Tamborra, Annamaria Piscazzi, Matteo Landriscina, Gianluigi Vendemiale, Gaetano Serviddio
Published 2016-01-01

<i>IDH1</i> Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment—Current State and Future Perspectives

by Fabiana Crispo, Michele Pietrafesa, Valentina Condelli, Francesca Maddalena, Giuseppina Bruno, Annamaria Piscazzi, Alessandro Sgambato, Franca Esposito, Matteo Landriscina
Published 2020-08-01

Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells

by Girolamo Spagnoletti, Valeria Li Bergolis, Annamaria Piscazzi, Francesca Giannelli, Valentina Condelli, Lorenza Sisinni, Giuseppe Bove, Giovanni Storto, Matteo Landriscina
Published 2018-04-01

Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma

by Donato Lacedonia, Matteo Landriscina, Giulia Scioscia, Pasquale Tondo, Incoronata Caccavo, Giuseppina Bruno, Guido Giordano, Annamaria Piscazzi, Maria Pia Foschino Barbaro
Published 2021-01-01

Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era

by Guido Giordano, Pietro Parcesepe, Giuseppina Bruno, Annamaria Piscazzi, Vincenzo Lizzi, Andrea Remo, Massimo Pancione, Mario Rosario D’Andrea, Elena De Santis, Luigi Coppola, Michele Pietrafesa, Alberto Fersini, Antonio Ambrosi, Matteo Landriscina
Published 2021-07-01